The Costs of Smoking and the Cost Effectiveness of Smoking-Cessation Programs

1990 ◽  
Vol 11 (2) ◽  
pp. 218 ◽  
Author(s):  
Anne Elixhauser
Keyword(s):  
Smoking Cessation ◽  
Cost Effectiveness ◽  
The Cost

Cost-Effectiveness of Pharmacological Interventions for Smoking Cessation: A Literature Review and a Decision Analytic Analysis

2002 ◽  
Vol 22 (1_suppl) ◽  
pp. 26-37 ◽  
Author(s):  
Fujian Song ◽  
James Raftery ◽  
Paul Aveyard ◽  
Chris Hyde ◽  
Pelham Barton ◽  
...  
Keyword(s):  
Smoking Cessation ◽  
Cost Effectiveness ◽  
Cost Effective ◽  
Decision Analytic Model ◽  
Relative Cost ◽  
Pharmacological Interventions ◽  
Relative Cost Effectiveness ◽  
Life Years ◽  
The Uk ◽  
The Cost

To evaluate the relative cost-effectiveness of nicotine replacement therapy (NRT) and bupropion SR for smoking cessation, the authors reviewed published studies and developed a decision analytic model from the UK National Health Services perspective. Irrespective of the methods or assumptions involved, the results of published studies consistently indicated that NRT for smoking cessation is cost-effective. No published studies have evaluated the relative cost-effectiveness of bupropion SR for smoking cessation. The results of the decision analyses indicated that, as compared with advice or counseling alone, the incremental cost per life-years saved is about $1,441~$3,455 for NRT, $920~$2,150 for bupropion SR, and $1,282~$2,836 for NRT plus bupropion SR. The cost-effectiveness of adding NRT and bupropion SR to advice or counseling for smoking cessation is better than many other accepted health care interventions.

Cost-Effectiveness of Cardiovascular Prevention Programs in Spain

1998 ◽  
Vol 14 (2) ◽  
pp. 320-330 ◽  
Author(s):  
Pedro Plans-rubió
Keyword(s):  
Smoking Cessation ◽  
Cost Effectiveness ◽  
Drug Treatment ◽  
Mild Hypertension ◽  
Severe Hypertension ◽  
Cardiovascular Prevention ◽  
Dietary Treatment ◽  
Prevention Programs ◽  
Ranking List ◽  
The Cost

AbstractIndividual programs for prevention of cardiovascular disease include dietary and drug treatment of hypercholesterolemia, hypertension treatment, and smoking cessation therapies. In this study, the cost-effectiveness of available cardiovascular prevention programs was assessed in Spain in terms of net cost per life-year gained (LYG). Cost-effectiveness ratios ranged from US $2,600 to $80,000 per LYG in men and from $4,500 to $230,000 per LYG in women. In men aged 40–59 years, the ranking of increasing cost-effectiveness was: smoking cessation ($2,608–3,738 per LYG); treatment of moderate and severe hypertension ($8,564–38,678 per LYG); treatment of mild hypertension ($11,906–59,840 per LYG); dietary treatment ($16,143–20,158 per LYG); and drug treatment of hypercholesterolemia ($33,850–81,010 per LYG). In women, the ranking list was: smoking cessation ($4,482–5,756 per LYG), treatment of moderate and severe hypertension ($9,585–57,983 per LYG), treatment of mild hypertension ($15,248–86,075 per LYG), dietary treatment ($57,175–62,154 per LYG); and drug treatment of hypercholesterolemia ($104,100–259,150 per LYG).

scholarly journals PRS24 THE COST-EFFECTIVENESS ANALYSIS OF VARENICLINE FOR SMOKING CESSATION IN POLAND

2009 ◽  
Vol 12 (7) ◽  
pp. A303
Author(s):  
J Walczak ◽  
G Nogas ◽  
A Dybek-Karpiuk ◽  
J Augustynska ◽  
J Stelmachowski ◽  
...  
Keyword(s):  
Smoking Cessation ◽  
Cost Effectiveness ◽  
Cost Effectiveness Analysis ◽  
Effectiveness Analysis ◽  
The Cost

scholarly journals PRS13 THE COST-EFFECTIVENESS OF VARENICLINE IN SMOKING CESSATION IN DENMARK

2008 ◽  
Vol 11 (6) ◽  
pp. A450 ◽  
Author(s):  
PB Poulsen ◽  
J Dollerup ◽  
H Keiding
Keyword(s):  
Smoking Cessation ◽  
Cost Effectiveness ◽  
The Cost

The cost-effectiveness of antidepressants for smoking cessation in chronic obstructive pulmonary disease (COPD) patients

Addiction ◽  
2009 ◽  
Vol 104 (12) ◽  
pp. 2110-2117 ◽  
Author(s):  
Constant P. Van Schayck ◽  
Janneke Kaper ◽  
Edwin J. Wagena ◽  
Emiel F. M. Wouters ◽  
Johannes L. Severens
Keyword(s):  
Chronic Obstructive Pulmonary Disease ◽  
Smoking Cessation ◽  
Cost Effectiveness ◽  
Pulmonary Disease ◽  
Chronic Obstructive ◽  
Obstructive Pulmonary Disease ◽  
Copd Patients ◽  
The Cost
Sign in / Sign up

Export Citation Format

Share Document